Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.78
Delayed Data
As of May 23
 +0.18 / +2.09%
Today’s Change
5.05
Today|||52-Week Range
8.86
+11.56%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.60
Today’s open8.62
Day’s range8.62 - 8.86
Volume815,935
Average volume (3 months)345,633
Market cap$663.2M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.08+1.22%
NVTAInvitae Corp+0.42+5.15%
RDNTRadNet Inc-0.02-0.39%
PTIProteostasis Therape...+0.76+7.03%
Data as of 05/23/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs